Literature DB >> 50465

Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection.

P F Fischinger, N Tuttle-Fuller, G Hüper, D P Bolognesi.   

Abstract

Cloned 3T3FL cells were synchronized in G1 phase of the cell cycle by deprivation of multiplication stimulatory activity of serum and were then infected with Moloney leukemia virus. Eclipse period of virus could be made to vary from less than 10 to 34 h. All virus release was completely dependent and occurred immediately after the first mitosis following serum reconstitution. Virus yield was not affected by the time of virus inoculation as related to the cell DNA synthetic phase. Colchicine arrested the cells in mitosis and prevented the formation of infectious virus. Viral proteins p10, p30, and gp71 were assayed in cell lysates during the growth curve of virus in synchronized cells. The group-specific determinants of each protein were measured in a competition radioimmunoassay. None of the virus proteins appeared during the eclipse period of the virus. All three proteins appeared simultaneously, coincident with mitosis, and continued to rise during the G1 phase. The absolute quantities of each protein were proportional to the amount of Moloney leukemia virus produced. The relative amounts of some of the viral proteins in the cell did not correspond to their content in purified virions suggesting several possible mechanisms of control.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50465      PMCID: PMC354664     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Int J Cancer       Date:  1970-07-15       Impact factor: 7.396

3.  Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures.

Authors:  P J Fischinger; T E O'Connor
Journal:  Virology       Date:  1970-06       Impact factor: 3.616

4.  Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen.

Authors:  M Strand; J T August
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

5.  Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.

Authors:  D P Bolognesi; R Luftig; J H Shaper
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

6.  Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses.

Authors:  R W Green; D P Bolognesi; W Schäfer; L Pister; G Hunsmann; F De Noronha
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

7.  Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus.

Authors:  S Nomura; P J Fischinger; C F Mattern; P T Peebles; R H Bassin; G P Friedman
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

8.  Cell-cycle dependent appearance of murine leukemia-sarcoma virus antigens.

Authors:  S Panem; V Schauf
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

9.  Incorporation of precursors into ribonucleic acid, protein, glycoprotein, and lipoprotein of avian myeloblastosis virions.

Authors:  M A Baluda; D P Nayak
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

10.  Properties of mouse leukemia viruses. VII. The major viral glycoprotein of friend leukemia virus. Isolation and physicochemical properties.

Authors:  V Moennig; H Frank; G Hunsmann; I Schneider; W Schafer
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

View more
  9 in total

1.  Cell cycle-dependent multiplication of avian adenoviruses in chicken embryo fibroblasts.

Authors:  V Kraft; I Tischer
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  The effect of cell synchronization upon the detection of T and B lymphoid cell receptors on two continuous lymphoid cell lines.

Authors:  S Krakowka; R Olsen; G Cockerell
Journal:  In Vitro       Date:  1977-02

3.  Characterization of the infection of equine fibroblasts by equine infectious anemia virus.

Authors:  P Klevjer-Anderson; W P Cheevers; T B Crawford
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.

Authors:  J G Levin; M J Rosenak
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  The correlation between tissue differentiation and production of mammary tumor virus (MTV) in transplanted murine mammary tumors. Electron microscopic observations.

Authors:  C Schöpper; E Fasske; R Fetting; H Themann
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

6.  Retrovirus gene expression during the cell cycle. I. Virus production, synthesis, and expression of viral proteins in Rauscher murine leukemia virus-infected mouse cells.

Authors:  I Balazs; J Caldarella
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  A novel murine oncornavirus with dual eco- and xenotropic properties.

Authors:  P J Fischinger; S Nomura; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

8.  Relationship of Friend murine leukemia virus production to growth and hemoglobin synthesis in cultured erythroleukemia cells.

Authors:  C C Sherton; L H Evans; E Polonoff; D Kabat
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

9.  Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.

Authors:  R S Metzgar; T Mohanakumar; D P Bolognesi
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.